Jill Chappell

Jill Chappell has extensive work experience in the field of clinical pharmacology. Jill has held the role of Director of Clinical Pharmacology at various companies, including Praxis Precision Medicines, Reata Pharmaceuticals, and Chimerix. In these positions, they provided scientific support for the planning, execution, and reporting of Phase 1 studies and reviewed clinical pharmacology regulatory documents.

In addition to their roles in the pharmaceutical industry, Jill Chappell also co-founded and served as the Board Chair of BRiCKs Alliance, a nonprofit organization that focuses on community education and collaboration to address issues like poverty.

Prior to these positions, Jill Chappell worked at PRA Health Sciences as the Director of Clinical Pharmacology and at ExecuPharm on assignment at Merck & Co. as a Senior Clinical Scientist. Jill also had a long tenure at Eli Lilly and Company, where they held various positions, including Principal Clinical Research Scientist/Clinical Pharmacologist and Senior Scientific Communications Associate. In these roles, they played a vital role in the clinical development of compounds in various therapeutic areas and contributed to the preparation and review of regulatory documents.

Overall, Jill Chappell's work experience demonstrates their expertise in clinical pharmacology and their commitment to making a positive impact in the healthcare industry.

Jill Chappell obtained a Bachelor of Arts degree in Chemistry from Kalamazoo College in the years 1989-1993. Jill then pursued further education at the University of Colorado School of Pharmacy, where they earned a B.S. and PharmD degree between unknown start and 1999 end years. Following this, Jill completed a Pharmacy Resident program and acquired a Doctor of Pharmacy degree at Mount Sinai Hospital, NY from 1999-2001, specializing in General Practice and Neurology.